China National Medicines Corporation Ltd. (SHA:600511)

Market Cap	22.21B
Revenue (ttm)	51.47B
Net Income (ttm)	1.95B
Shares Out	754.50M
EPS (ttm)	2.58
PE Ratio	11.40
Forward PE	10.64
Dividend	0.80 (2.72%)
Ex-Dividend Date	Jun 18, 2025

Volume	4,219,600
Average Volume	5,737,462
Open	29.63
Previous Close	29.63
Day's Range	29.40 - 29.68
52-Week Range	27.12 - 38.00
Beta	0.37
RSI	43.31
Earnings Date	Aug 21, 2025

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 3,104
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2024, SHA:600511's revenue was 50.60 billion, an increase of 1.81% compared to the previous year's 49.70 billion. Earnings were 2.00 billion, a decrease of -6.80%.